U.S. markets open in 2 hours 17 minutes

Tekla Life Sciences Investors (HQL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
20.00-0.50 (-2.44%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close20.50
Open20.49
Bid0.00 x 900
Ask0.00 x 900
Day's Range19.78 - 20.56
52 Week Range11.45 - 22.32
Volume128,597
Avg. Volume79,600
Market Cap477.664M
Beta (5Y Monthly)0.97
PE Ratio (TTM)3.88
EPS (TTM)5.15
Earnings DateN/A
Forward Dividend & Yield1.72 (8.28%)
Ex-Dividend DateFeb 25, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    Tekla World Healthcare Fund Paid Distribution

    On February 26, 2021, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $46,585,441 of which $57,287,486 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Healthcare Opportunities Fund Paid Distribution

    On February 26, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $154,173,967 of which $157,978,325 represents net unrealized appreciation of portfolio securities.

  • Business Wire

    Tekla Life Sciences Investors Declares Distribution

    On February 16, 2021, Tekla Life Sciences Investors declared a distribution of $0.43 per share. The record date for the distribution is February 26, 2021 and the payable date is March 31, 2021. The Fund will trade ex-distribution on February 25, 2021.